Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Metastatic Castration-resistant Prostate Cancer
Related studies linked through entity extraction aliases.
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of INKmune in Patients With mCRPC (CaRe Prostate)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PRostate Olaparib Real World Evidence Study
- Status
- RECRUITING
- Phase
- N/A
Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Status
- UNKNOWN
- Phase
- PHASE2
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
64Cu-GRIP B in Patients With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)
- Status
- UNKNOWN
- Phase
- NA
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC
- Status
- RECRUITING
- Phase
- PHASE2
Phase 0/1 Study of 212Pb-NG001 in mCRPC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Checkpoint Inhibitors and SBRT for MCRPC
- Status
- COMPLETED
- Phase
- PHASE2
Pre-approval Single-patient Expanded Access for Talazoparib (PF-06944076)
- Status
- AVAILABLE
- Phase
- N/A
Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1